Research Analysts Offer Predictions for Accolade, Inc.’s FY2026 Earnings (NASDAQ:ACCD)

Accolade, Inc. (NASDAQ:ACCD) – Equities research analysts at William Blair issued their FY2026 earnings estimates for shares of Accolade in a research note issued on Thursday, April 25th. William Blair analyst R. Daniels forecasts that the company will post earnings per share of ($1.01) for the year. William Blair has a “Outperform” rating on the stock. The consensus estimate for Accolade’s current full-year earnings is ($1.20) per share.

A number of other research analysts have also recently issued reports on the stock. Needham & Company LLC lowered their price target on shares of Accolade from $17.00 to $13.00 and set a “buy” rating for the company in a research report on Friday. Canaccord Genuity Group decreased their target price on shares of Accolade from $18.00 to $16.00 and set a “buy” rating for the company in a report on Friday. Morgan Stanley decreased their target price on shares of Accolade from $13.00 to $12.00 and set an “equal weight” rating for the company in a report on Friday. Truist Financial decreased their target price on shares of Accolade from $16.00 to $14.00 and set a “buy” rating for the company in a report on Friday. Finally, SVB Leerink initiated coverage on shares of Accolade in a report on Monday, February 26th. They issued an “outperform” rating and a $16.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $14.80.

Accolade Trading Down 14.1 %

Shares of NASDAQ ACCD opened at $7.89 on Monday. Accolade has a 1 year low of $6.33 and a 1 year high of $17.00. The stock has a market cap of $610.76 million, a P/E ratio of -5.93 and a beta of 2.08. The firm has a 50-day moving average of $9.66 and a 200 day moving average of $9.93. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.35 and a quick ratio of 2.35.

Accolade (NASDAQ:ACCD) last announced its earnings results on Thursday, April 25th. The company reported ($0.10) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.01. Accolade had a negative net margin of 24.09% and a negative return on equity of 22.57%. The firm had revenue of $124.80 million for the quarter, compared to analyst estimates of $123.91 million. During the same quarter in the previous year, the firm posted ($0.42) EPS. The company’s revenue for the quarter was up 26.1% compared to the same quarter last year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of ACCD. AE Wealth Management LLC acquired a new stake in shares of Accolade during the third quarter worth about $400,000. Handelsbanken Fonder AB lifted its position in shares of Accolade by 14.8% during the third quarter. Handelsbanken Fonder AB now owns 16,765 shares of the company’s stock worth $177,000 after purchasing an additional 2,165 shares in the last quarter. Raymond James & Associates acquired a new stake in shares of Accolade during the third quarter worth about $272,000. Bank of New York Mellon Corp lifted its position in shares of Accolade by 2.7% during the third quarter. Bank of New York Mellon Corp now owns 230,092 shares of the company’s stock worth $2,434,000 after purchasing an additional 6,069 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Accolade by 84.3% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,928 shares of the company’s stock worth $126,000 after purchasing an additional 5,455 shares in the last quarter. Institutional investors and hedge funds own 84.99% of the company’s stock.

Accolade Company Profile

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians.